News
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.
Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in.
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to 10–16% (from 16-24%) and revenue growth projections to 8-14% (from 13-21%) at ...
Scientists map how the brain integrates hormonal and neural signals from the body to control appetite, energy use, and reward pathways, revealing targets for next-generation anti-obesity drugs. This ...
SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...
Many people around the world are turning to new prescription drugs to help them lose weight. These medicines can work very well while you are taking them, but a new study suggests that the weight loss ...
Accusing doctors of “dishing out” medications for weight loss and then labelling people “cheats” for using them is a ...
3h
Everyday Health on MSNGLP-1 Pill Helped People With Obesity Lose Almost 30 Pounds in New TrialPeople who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.
A review study published in the Annals of Internal Medicine looks at the effect of weight loss before IVF on reproductive outcomes. Prof Ying Cheong, Professor of Reproductive Medicine and Honorary ...
Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
Shares of WW International Inc., the company known as WeightWatchers, reversed their early gains Monday despite better-than-expected second-quarter revenue amid robust demand for GLP-1 obesity ...
Shares of WW International Inc., the company known as WeightWatchers, pared back their early gains Monday despite better-than-expected second-quarter revenue amid robust demand for GLP-1 obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results